Tech Transfer

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork, a UVA Discovery Park.

The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.

Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).

Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…

Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…

ITHRIV includes the University of Virginia, Inova Health System, Virginia Tech and Carilion Clinic as partners, with the Center for Open Science and UVA’s Licensing & Ventures Group as affiliates.

University of Virginia School of Medicine professor Lee Ritterband created SHUTi (Sleep Healthy Using the Internet) – a digital therapeutic that uses cutting-edge technology to administer cognitive behavioral therapy for people suffering from insom

Local biotechnology industry leader Nikki Hastings, PhD, has been named the first Executive Director of the CvilleBioHub, a non-profit that connects and supports the Charlottesville-area biotechnology sector.  CvilleBioHub will receive strategic pla

The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).